Zobrazeno 1 - 10
of 20
pro vyhledávání: '"инозитол"'
Publikováno v:
REPRODUCTIVE ENDOCRINOLOGY; No. 62 (2021); 104-109
РЕПРОДУКТИВНАЯ ЭНДОКРИНОЛОГИЯ; № 62 (2021); 104-109
РЕПРОДУКТИВНА ЕНДОКРИНОЛОГІЯ; № 62 (2021); 104-109
РЕПРОДУКТИВНАЯ ЭНДОКРИНОЛОГИЯ; № 62 (2021); 104-109
РЕПРОДУКТИВНА ЕНДОКРИНОЛОГІЯ; № 62 (2021); 104-109
Despite the chemical similarities between myo-inositol and D-chiro-inositol and their synergistic effects on insulin sensitivity, they serve different functions. Insulin resistance is one of the etiological factors in the development of polycystic ov
Autor:
Chandanvir Saini
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 16, Iss 8, Pp 648-653 (2020)
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine); Vol. 16 No. 8 (2020); 648-653
Международный эндокринологический журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16 № 8 (2020); 648-653
Міжнародний ендокринологічний журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16 № 8 (2020); 648-653
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine); Vol. 16 No. 8 (2020); 648-653
Международный эндокринологический журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16 № 8 (2020); 648-653
Міжнародний ендокринологічний журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16 № 8 (2020); 648-653
Autoimmune thyroiditis (AT) is considered to be the most common autoimmune disease. It is currently accepted that genetic susceptibility, environmental factors, and immune disorders contribute to its development. With regard to nutritional factors, e
Publikováno v:
REPRODUCTIVE ENDOCRINOLOGY; No. 62 (2021); 30-33
РЕПРОДУКТИВНАЯ ЭНДОКРИНОЛОГИЯ; № 62 (2021); 30-33
РЕПРОДУКТИВНА ЕНДОКРИНОЛОГІЯ; № 62 (2021); 30-33
РЕПРОДУКТИВНАЯ ЭНДОКРИНОЛОГИЯ; № 62 (2021); 30-33
РЕПРОДУКТИВНА ЕНДОКРИНОЛОГІЯ; № 62 (2021); 30-33
Research objective: to study the effect of myo-inositol (MI), folic acid (FA) and cyanocobalamin in mono- and complex therapy on the classical fertility rates and the level of DNA fragmentation in sperm in men with low reproductive function, and on t
Publikováno v:
REPRODUCTIVE ENDOCRINOLOGY; No. 61 (2021); 95-100
РЕПРОДУКТИВНАЯ ЭНДОКРИНОЛОГИЯ; № 61 (2021); 95-100
РЕПРОДУКТИВНА ЕНДОКРИНОЛОГІЯ; № 61 (2021); 95-100
РЕПРОДУКТИВНАЯ ЭНДОКРИНОЛОГИЯ; № 61 (2021); 95-100
РЕПРОДУКТИВНА ЕНДОКРИНОЛОГІЯ; № 61 (2021); 95-100
In recent years, Ukraine has seen a significant deterioration in the reproductive health of women in the face of declining birth rates. One of the main causes of comorbidity of infertility and background pathologies is the insufficient supply of a wo
В статье приведены обзорные данные о применении фолатов и мио-инозитола в качестве микронутриентов на этапе планирования беременности.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea768327688bd610e8bb6405be0b1c6c
Autor:
Thalamati, Sujana
Publikováno v:
Reproductive Endocrinology; № 56 (2020); 96-99
Репродуктивная эндокринология; № 56 (2020); 96-99
Репродуктивна ендокринологія; № 56 (2020); 96-99
Репродуктивная эндокринология; № 56 (2020); 96-99
Репродуктивна ендокринологія; № 56 (2020); 96-99
Polycystic ovary syndrome (PCOS) is a symptom complex associated with increased amounts of circulating androgens in females, increased insulin resistance and obesity. The drugs, Myo-inositol, D-chiro-inositol and Metformin, which are insulin sensitiz
Autor:
Nosenko, O. M., Novikova, O. V.
Publikováno v:
Reproductive Endocrinology; № 56 (2020); 23-34
Репродуктивная эндокринология; № 56 (2020); 23-34
Репродуктивна ендокринологія; № 56 (2020); 23-34
Репродуктивная эндокринология; № 56 (2020); 23-34
Репродуктивна ендокринологія; № 56 (2020); 23-34
The article presents literature data on the role of inositol and its derivatives in human body, results of the myo-inositol (MI) use in gynecological diseases, treatment of female and male infertility, including in cycles of assisted reproductive tec
Autor:
Roseff, S., Montenegro, M.
Publikováno v:
Reproductive Endocrinology; № 55 (2020); 94-98
Репродуктивная эндокринология; № 55 (2020); 94-98
Репродуктивна ендокринологія; № 55 (2020); 94-98
Репродуктивная эндокринология; № 55 (2020); 94-98
Репродуктивна ендокринологія; № 55 (2020); 94-98
he aim of this paper is to critically analyze the composition of many inositol-based products currently used to treat polycystic ovary syndrome (PCOS). Several different combinations of myo-inositol and D-chiro-inositol, withand without additional co
Publikováno v:
РЕПРОДУКТИВНА ЕНДОКРИНОЛОГІЯ; № 60 (2021); 72-76
РЕПРОДУКТИВНАЯ ЭНДОКРИНОЛОГИЯ; № 60 (2021); 72-76
REPRODUCTIVE ENDOCRINOLOGY; No. 60 (2021); 72-76
РЕПРОДУКТИВНАЯ ЭНДОКРИНОЛОГИЯ; № 60 (2021); 72-76
REPRODUCTIVE ENDOCRINOLOGY; No. 60 (2021); 72-76
The reproductive health of parents is the onset and further physiological course of pregnancy, childbirth and health of the unborn child. Saving of reproductive health can be considered as protecting the family from factors with “reproductive toxic
Publikováno v:
РЕПРОДУКТИВНА ЕНДОКРИНОЛОГІЯ; № 60 (2021); 96-100
РЕПРОДУКТИВНАЯ ЭНДОКРИНОЛОГИЯ; № 60 (2021); 96-100
REPRODUCTIVE ENDOCRINOLOGY; No. 60 (2021); 96-100
РЕПРОДУКТИВНАЯ ЭНДОКРИНОЛОГИЯ; № 60 (2021); 96-100
REPRODUCTIVE ENDOCRINOLOGY; No. 60 (2021); 96-100
Myo-inositol is considered an additional insulin-sensitive supplement that may benefit women with polycystic ovary syndrome (PCOS). Correcting insulin resistance and lowering circulating insulin levels are key therapeutic options in the PCOS treatmen